Nam W. Kim Ph.D

Chief Executive Officer & Chief Technology Officer


Nam is a seasoned scientist and executive with over 25 years of experience in developing and commercializing novel diagnostics tests at several cutting-edge biotechnology companies including  Geron, and diaDexus where he was responsible for the development of novel diagnostic and prognostic markers for cancer and cardiovascular diseases.


Sholeh Jahanfard

President & Chief Operating Officer



Sholeh is a clinical diagnostic expert with over 35 years of clinical diagnostics and life-science industry including  Kaiser Permanente, LifeScan (a Johnson & Johnson Company), DiaSorin, Incell Dx and Enzo LifeSciences. She has launched several novel tests both in the U.S. and internationally and managed the sales and marketing activities for ENZO LifeScience in Europe. 

Screen Shot 2020-07-25 at 3.57.29 PM.png

Shahram Gholami M.D.

Chief Medical Officer

Shahram is an internationally recognized urologist in the field of minimally invasive laparoscopic and robotic surgery and cystoscopy.  He is a practicing clinician with a renowned urology clinic located in the heart of silicon valley and affiliated with Good Samaritan Hospital and Stanford University.

About Us

At KDx Diagnostics, we believe in the advancement of bladder cancer recognition. Ever since our establishment in 2016, we have worked endlessly to achieve the highest sensitivity and specificity bladder cancer test. With the creation of our URO17®️ test, we have not only achieved such an inexpensive and non-invasive test, but also one that is simpler to use for the patient with results that are more accurate than ever before. We hope with the introduction of the URO17®️, we can strive for quicker recognition and response to the dangers of cancer and help out patients achieve a peaceful and care-free life.

Consultants and Advisors


Doug Sweet – Former VP Marketing Agilent, Roche, Syva & Mol Devices
Vladimir Ostioich– Co-founder, Abaxis Inc.
Melya Crameri-Hughes – Ventec Partners

Clinical and Scientific/Collaborators:

Kenneth Shroyer, M.D., Ph.D. - Stony Brook Medicine

Luisa Escobar-Hoyos, M.D., Ph.D. - Stony Brook Medicine

Sima Porten, M.D., MPH – UCSF

Nikhil Vasdev, MBBS, MRCS, ChM, FRCS – Lister Hospital


FDA Regulatory:

Mark Sarno – CEO Vision Biotechnology
Erika B. Ammirati - Regulatory Consulting